Search

Your search keyword '"Madruga Garrido, M."' showing total 114 results

Search Constraints

Start Over You searched for: Author "Madruga Garrido, M." Remove constraint Author: "Madruga Garrido, M."
114 results on '"Madruga Garrido, M."'

Search Results

3. Delphi consensus on recommendations for the treatment of spinal muscular atrophy in Spain (RET-AME consensus)

4. Consenso Delphi de las recomendaciones para el tratamiento de los pacientes con atrofia muscular espinal en España (consenso RET-AME)

7. Safety and efficacy of tamoxifen in boys with Duchenne muscular dystrophy (TAMDMD): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

8. VP.55 Fatigue, pain, breathing, voice, fatigability, sleep, rest and vulnerability as meaningful outcomes in SMA care: the patients´ and caregivers' voice

10. Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial

11. Design of a Non-Interventional Study to Validate a Set of Patient- and Caregiver-Oriented Measurements to Assess Health Outcomes in Spinal Muscular Atrophy (SMA-TOOL Study)

12. Trastornos de tics e impulso premonitorio: validación de la versión española de la «Escala para el Impulso Premonitorio al Tic» en niños y adolescentes

13. MITOCHONDRIAL DISEASES & METABOLIC MYOPATHIES

15. O.2Growth differentiation factor 15 is a valuable biomarker of therapeutic response for TK2 deficient myopathy

16. P.60A retrospective study of the combination of pyrimidine nucleos(t)ides in patients with thymidine kinase 2 (TK2) deficiency

18. Analysis of shared heritability in common disorders of the brain

19. Analysis of shared heritability in common disorders of the brain

20. Investigation of previously implicated genetic variants in chronic tic disorders: a transmission disequilibrium test approach

22. Dystroglycanopathy: Description of the first patient cohort in Spain

25. Gaucher disease type 3 in Spain. Outcomes and characterization

35. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

36. Vitamin D levels in children and adolescents with chronic tic disorders: a multicentre study

37. Hair cortisol-a stress marker in children and adolescents with chronic tic disorders? A large European cross-sectional study

38. Yale Global Tic Severity Scale (YGTSS): Psychometric Quality of the Gold Standard for Tic Assessment Based on the Large-Scale EMTICS Study

39. Collaborative model for diagnosis and treatment of very rare diseases: experience in Spain with thymidine kinase 2 deficiency

40. Elevated common variant genetic risk for tourette syndrome in a densely-affected pedigree

41. Whole-exome sequencing identifies genes associated with Tourette's disorder in multiplex families

42. European Multicentre Tics in Children Studies (EMTICS)

43. De Novo Sequence and Copy Number Variants Are Strongly Associated with Tourette Disorder and Implicate Cell Polarity in Pathogenesis

44. The Premonitory Urge for Tics Scale in a large sample of children and adolescents:psychometric properties in a developmental context. An EMTICS study

45. Deoxynucleoside Therapy for Thymidine Kinase 2-Deficient Myopathy

46. Analysis of shared heritability in common disorders of the brain

47. Retrospective natural history of thymidine kinase 2 deficiency

48. Inusual complicación en la edad pediátrica: encefalopatía de Wernicke asociada a nutrición parenteral deficiente en tiamina

49. HMGCS1 variants cause rigid spine syndrome amenable to mevalonic acid treatment in an animal model.

Catalog

Books, media, physical & digital resources